Rxo (RXO) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Rxo (RXO) over the last 4 years, with Q4 2025 value amounting to $0.26.
- Rxo's Debt to Equity rose 1484.07% to $0.26 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.26, marking a year-over-year increase of 1484.07%. This contributed to the annual value of $0.26 for FY2025, which is 1484.07% up from last year.
- As of Q4 2025, Rxo's Debt to Equity stood at $0.26, which was up 1484.07% from $0.26 recorded in Q3 2025.
- Rxo's Debt to Equity's 5-year high stood at $0.78 during Q1 2023, with a 5-year trough of $0.01 in Q3 2022.
- In the last 4 years, Rxo's Debt to Equity had a median value of $0.43 in 2023 and averaged $0.46.
- As far as peak fluctuations go, Rxo's Debt to Equity skyrocketed by 790271.19% in 2023, and later plummeted by 7112.96% in 2024.
- Rxo's Debt to Equity (Quarter) stood at $0.78 in 2022, then decreased by 22.03% to $0.6 in 2023, then tumbled by 62.23% to $0.23 in 2024, then grew by 14.84% to $0.26 in 2025.
- Its last three reported values are $0.26 in Q4 2025, $0.26 for Q3 2025, and $0.25 during Q2 2025.